Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Undervalued stocks
Growth stocks
Momentum stocks
Trend-Following Stocks
Quality stocks
Yield stocks
Investment Themes
Financial Data
Biotechnology
The future of mobility
Cybersecurity
In Vino Veritas
The Vegan Market
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Strategic Metals
The SPAC
The Cannabis Industry
In Vino Veritas
Water
Europe's family businesses
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Inari Medical, Inc.
News
Summary
NARI
US45332Y1091
INARI MEDICAL, INC.
(NARI)
Add to my list
Report
Delayed Nasdaq -
04:00 2022-06-29 pm EDT
69.28
USD
-0.12%
06/24
BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) added to Russell Small Cap Comp Value Index
CI
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) added to Russell 3000E Value Index
CI
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 400
05/03/2022 | 12:00am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 400
© S&P Capital IQ 2022
All news about INARI MEDICAL, INC.
06/24
BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) added to Russell Small Cap Comp Value Index
CI
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) added to Russell 3000E Value Index
CI
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) added to Russell 2500 Value Index
CI
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) added to Russell 3000 Value Index
CI
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) added to Russell 2000 Value Index
CI
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) dropped from Russell 2000 Growth-Defensive Index
CI
06/24
INARI MEDICAL, INC.(NASDAQGS
: NARI) dropped from Russell 2000 Defensive Index
CI
06/21
Inari Medical's Shares Rise After Piper Sandler Initiates Coverage
MT
06/21
Piper Sandler Starts Inari Medical at Overweight With $100 Price Target
MT
More news
Analyst Recommendations on INARI MEDICAL, INC.
06/24
BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/21
Piper Sandler Starts Inari Medical at Overweight With $100 Price Target
MT
03/14
Canaccord Genuity Adjusts Inari Medical's Price Target to $96 from $102, Keeps Buy Rati..
MT
More recommendations
Financials (USD)
Sales 2022
365 M
-
-
Net income 2022
-38,5 M
-
-
Net cash 2022
316 M
-
-
P/E ratio 2022
-93,1x
Yield 2022
-
Capitalization
3 681 M
3 681 M
-
EV / Sales 2022
9,22x
EV / Sales 2023
7,71x
Nbr of Employees
800
Free-Float
84,9%
More Financials
Chart INARI MEDICAL, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short Term
Mid-Term
Long Term
Trends
Bullish
Bearish
Bearish
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
69,28 $
Average target price
105,00 $
Spread / Average Target
51,6%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
William H. Hoffman
President, Chief Executive Officer & Director
Mitchell C. Hill
Chief Financial Officer
Don B. Milder
Chairman
Thomas Tu
Chief Medical Officer
Tara Dunn
VP-Clinical Affairs & Market Development
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
INARI MEDICAL, INC.
-24.09%
3 685
MASIMO CORPORATION
-53.18%
7 608
NOVOCURE LIMITED
-4.06%
7 533
SHOCKWAVE MEDICAL, INC.
8.99%
6 999
GETINGE AB
-40.22%
6 350
IRAY TECHNOLOGY COMPANY LIMITED
-8.15%
4 986
More Results
Slave